Literature DB >> 24318937

Body composition and cardiometabolic disease risk factors in captive baboons (Papio hamadryas sp.): sexual dimorphism.

Paul B Higgins1, Perla J Rodriguez, V Saroja Voruganti, Vicki Mattern, Raul A Bastarrachea, Karen Rice, Timothy Raabe, Anthony G Comuzzie.   

Abstract

Baboons (Papio hamadryas sp.) exhibit significant sexual dimorphism in body size. Sexual dimorphism is also exhibited in a number of circulating factors associated with risk of cardiometabolic disease. We investigated whether sexual dimorphism in body size and composition underlie these differences. We examined data from 28 male and 24 female outdoor group-housed young adult baboons enrolled in a longitudinal observational study of cardiometabolic disease risk factors. Animals were sedated with ketamine HCl (10 mg/kg) before undergoing venous blood draws, basic body measurements, and dual-energy X-ray absorptiometry body composition scans. Percentage glycated hemoglobin A1c (%HbA1c ) was measured in whole blood. Serum samples were analyzed for glucose, insulin, C-peptide, high-density lipoprotein, and triglyceride concentrations. Males were heavier and had greater body length and lean tissue mass than females. Females had a greater body fat percentage relative to males (10.8 ± 6.4 vs. 6.9 ± 4.0, P = 0.01). Although C-peptide, fasting glucose, and %HbA1c did not differ between the sexes, females had greater fasting insulin and triglyceride compared to their male counterparts. Insulin and percentage body fat were significantly correlated in males (r = 0.61, P = 0.001) and to a lesser extent in females (r = 0.43, P = 0.04). Overall, relations between adiposity and fasting insulin and fasting triglyceride were stronger in males. After accounting for differences in percentage body fat, fasting insulin and triglyceride were no longer statistically different between males and females. Despite stronger correlations between relative adiposity and insulin and triglyceride in males, the higher fasting insulin and triglyceride of female baboons may be underlain by their greater relative body fat masses.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  baboon; body fat; insulin; sex differences; triglyceride

Mesh:

Substances:

Year:  2013        PMID: 24318937      PMCID: PMC4025923          DOI: 10.1002/ajpa.22357

Source DB:  PubMed          Journal:  Am J Phys Anthropol        ISSN: 0002-9483            Impact factor:   2.868


  29 in total

1.  Impaired insulin-mediated antilipolysis and lactate release in adipose tissue of upper-body obese women.

Authors:  Birgitte Nellemann; Lars C Gormsen; Lars P Sørensen; Jens S Christiansen; Søren Nielsen
Journal:  Obesity (Silver Spring)       Date:  2011-09-29       Impact factor: 5.002

2.  Serum leptin levels as a marker for a syndrome X-like condition in wild baboons.

Authors:  William A Banks; Jeanne Altmann; Robert M Sapolsky; Jane E Phillips-Conroy; John E Morley
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

Review 4.  Metabolic actions of insulin in men and women.

Authors:  Faidon Magkos; Xuewen Wang; Bettina Mittendorfer
Journal:  Nutrition       Date:  2010-04-14       Impact factor: 4.008

5.  Weight growth in savannah baboons: a longitudinal study from birth to adulthood.

Authors:  D M Glassman; A M Coelho; K D Carey; C A Bramblett
Journal:  Growth       Date:  1984

Review 6.  Determinants of VLDL-triglycerides production.

Authors:  Søren Nielsen; Fredrik Karpe
Journal:  Curr Opin Lipidol       Date:  2012-08       Impact factor: 4.776

Review 7.  Sex differences in lipid and lipoprotein metabolism: it's not just about sex hormones.

Authors:  Xuewen Wang; Faidon Magkos; Bettina Mittendorfer
Journal:  J Clin Endocrinol Metab       Date:  2011-04       Impact factor: 5.958

8.  Cross-sectional growth standards for captive baboons: II. Organ weight by body weight.

Authors:  M C Mahaney; M M Leland; S Williams-Blangero; Y N Marinez
Journal:  J Med Primatol       Date:  1993 Sep-Oct       Impact factor: 0.667

9.  Association of monocyte chemoattractant protein-1 with adipocyte number, insulin resistance and liver function markers.

Authors:  Tanushree Bose; Juan Carlos Lopez Alvarenga; M Elizabeth Tejero; V Saroja Voruganti; J Michael Proffitt; Jeanne H Freeland-Graves; Shelley A Cole; Anthony G Comuzzie
Journal:  J Med Primatol       Date:  2009-08-21       Impact factor: 0.667

10.  Increased VLDL-triglyceride secretion precedes impaired control of endogenous glucose production in obese, normoglycemic men.

Authors:  Lars P Sørensen; Esben Søndergaard; Birgitte Nellemann; Jens S Christiansen; Lars C Gormsen; Søren Nielsen
Journal:  Diabetes       Date:  2011-08-01       Impact factor: 9.461

View more
  4 in total

1.  Central GIP signaling stimulates peripheral GIP release and promotes insulin and pancreatic polypeptide secretion in nonhuman primates.

Authors:  Paul B Higgins; Robert E Shade; Irám P Rodríguez-Sánchez; Magdalena Garcia-Forey; M Elizabeth Tejero; V Saroja Voruganti; Shelley A Cole; Anthony G Comuzzie; Franco Folli
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-08-16       Impact factor: 4.310

2.  Occipital condyle width (OCW) is a highly accurate predictor of body mass in therian mammals.

Authors:  Russell K Engelman
Journal:  BMC Biol       Date:  2022-02-07       Impact factor: 7.431

Review 3.  Use and Importance of Nonhuman Primates in Metabolic Disease Research: Current State of the Field.

Authors:  Peter J Havel; Paul Kievit; Anthony G Comuzzie; Andrew A Bremer
Journal:  ILAR J       Date:  2017-12-01

Review 4.  Nonhuman Primates and Translational Research-Cardiovascular Disease.

Authors:  Laura A Cox; Michael Olivier; Kimberly Spradling-Reeves; Genesio M Karere; Anthony G Comuzzie; John L VandeBerg
Journal:  ILAR J       Date:  2017-12-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.